Clement Kabakama¹*, Abdul Rafey Usmani² and Zahra D Khan³

¹Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Tanzania
²Department of Pediatric, University of Dodoma Teaching Hospital, Tanzania
³Department of Cardiology, TMJ Multi Speciality Hospital, Tanzania

*Corresponding Author: Clement Kabakama, Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Tanzania.

Received: July 12, 2021; Published: July 28, 2021

Abstract

Rheumatic Heart Disease (RHD) is an autoimmune response to group A-streptococcus infections of the upper respiratory tract which may result in carditis or inflammation of the mitral and aortic valves if left untreated. Rheumatic Heart Disease causes an acute generalized inflammatory response and an illness that affects certainly parts of the body mainly Heart, Joints, Brain and skin, Patients with Rheumatic Heart Disease are often severally unwell and they are in great pain and require Hospitalisation. Despite of that it has been postulated streptococcal infection seems to play an important role for clinical presentation shows a streptococcal pharyngitis but streptococcal cellulitis has never been implicated, common feature is a painful migratory arthritis which is present in approximately 80% of patients. There is a link with class-I human leukocyte antigens (HLAs) which has been found. However, evidence which exists suggests that elevated immune complex levels in blood samples from patients with RHD are associated with HLA-B5. Recently it has been estimated that 33.4 million people worldwide have rheumatic heart disease and that 300,000 - 500,000 new cases of rheumatic fever occur annually, with 230,000 deaths resulting from its complications at the same Time at the same time, The World Heart Federation non-communicable disease action plan, developed for the World Health Assembly in 2013, called for a 25% reduction in premature mortality from RHD by the year 2025. This case report discusses about management and prevention of further complications due to rheumatic heart disease.

Keywords: Rheumatic Heart Disease (RHD); Human Leukocyte Antigens (HLAs); Statins Therapy

References

1. Abernethy M., et al. “Doppler echocardiography and the early diagnosis of carditis in acute rheumatic fever”. Australian and New Zealand Journal of Medicine5 (1994): 530-535.
2. Shulman ST. “Rheumatic heart disease in developing countries”. The New England Journal of Medicine20 (2007): 20-89.
3. De Crombrugghe G., et al. “The Limitations of the Rheumatogenic Concept for Group A Streptococcus: Systematic Review and Genetic Analysis”. Clinical Infectious Diseases7 (2020): 1453-1460.
4. Guilherme L and Kalil J. “Rheumatic Heart Disease: Molecules Involved in Valve Tissue Inflammation Leading to the Autoimmune Process and Anti-S. pyogenes Vaccine”. Frontiers in Immunology 4 (2013): 352.
5. Gewitz MH., et al. “Revision of the Jones Criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography: a scientific statement from the American Heart Association”. Circulation 20 (2015): 1806-1818.
6. Hafez M., et al. “HLA antigens and acute rheumatic fever: evidence for a recessive susceptibility gene linked to HLA”. Genetic Epidemiology 3 (1985): 273-282.
7. Anastasiou Nana MI., et al. “HLA-DR typing and lymphocyte subset evaluation in rheumatic heart disease: a search for immune response factors”. American Heart Journal 5 (1986): 992-997.
8. Anwar AM., et al. “Validation of a new score for the assessment of mitral stenosis using real-time three- dimensional echocardiography”. Journal of the American Society of Echocardiography 1 (2010): 13-22.
9. Ayoub EM., et al. “Association of class II human histocompatibility leukocyte antigens with rheumatic fever”. The Journal of Clinical Investigation 6 (1986): 2019-2026.
10. Joseph N., et al. “Clinical spectrum of rheumatic Fever and rheumatic heart disease: a 10 year experience in an urban area of South India”. North American Journal of Medical Sciences11 (2013): 647-652.
11. Sikder S., et al. “Group G Streptococcus Induces an Autoimmune Carditis Mediated by Interleukin 17A and Interferon γ in the Lewis Rat Model of Rheumatic Heart Disease”. The Journal of Infectious Diseases2 (2018): 324-335.
12. Wilson NJ., et al. “New Zealand guidelines for the diagnosis of acute rheumatic fever: small increase in the incidence of definite cases compared to the American Heart Association Jones criteria”. The New Zealand Medical Journal1379 (2013): 50-59.
13. Bilavsky E., et al. “Effect of benzathine penicillin treatment on antibiotic susceptibility of viridans streptococci in oral flora of patients receiving secondary prophylaxis after rheumatic fever”. Journal of Infection4 (2008): 244-248.

Citation

Citation: Clement Kabakama., et al. “Do Statins Therapy Included as Rationale Treatment and Management for Rheumatic Heart Disease: A Case Report”. Acta Scientific Gastrointestinal Disorders 4.8 (2021): 74-78.

Copyright

Copyright: © 2021 Clement Kabakama., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.